nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—Venous thrombosis—Carboplatin—bone cancer	0.031	0.0653	CcSEcCtD
Hydroxocobalamin—Fluid overload—Carboplatin—bone cancer	0.0269	0.0566	CcSEcCtD
Hydroxocobalamin—Extravasation—Carboplatin—bone cancer	0.0191	0.0404	CcSEcCtD
Hydroxocobalamin—Haemolysis—Cisplatin—bone cancer	0.0154	0.0325	CcSEcCtD
Hydroxocobalamin—Phlebitis—Carboplatin—bone cancer	0.0141	0.0297	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Cisplatin—bone cancer	0.00908	0.0191	CcSEcCtD
Hydroxocobalamin—Fluid overload—Cisplatin—bone cancer	0.00788	0.0166	CcSEcCtD
Hydroxocobalamin—Sensitisation—Epirubicin—bone cancer	0.00705	0.0149	CcSEcCtD
Hydroxocobalamin—Sensitisation—Doxorubicin—bone cancer	0.00652	0.0137	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Epirubicin—bone cancer	0.00637	0.0134	CcSEcCtD
Hydroxocobalamin—Haematochezia—Epirubicin—bone cancer	0.00625	0.0132	CcSEcCtD
Hydroxocobalamin—Infection—Carboplatin—bone cancer	0.00592	0.0125	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Doxorubicin—bone cancer	0.00589	0.0124	CcSEcCtD
Hydroxocobalamin—Haematochezia—Doxorubicin—bone cancer	0.00578	0.0122	CcSEcCtD
Hydroxocobalamin—Extravasation—Cisplatin—bone cancer	0.00562	0.0118	CcSEcCtD
Hydroxocobalamin—Pain—Carboplatin—bone cancer	0.0051	0.0107	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carboplatin—bone cancer	0.00471	0.00993	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Epirubicin—bone cancer	0.00466	0.00983	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—bone cancer	0.00431	0.0091	CcSEcCtD
Hydroxocobalamin—Folliculitis—Methotrexate—bone cancer	0.00428	0.00902	CcSEcCtD
Hydroxocobalamin—Phlebitis—Cisplatin—bone cancer	0.00413	0.00871	CcSEcCtD
Hydroxocobalamin—Folliculitis—Epirubicin—bone cancer	0.004	0.00844	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Cisplatin—bone cancer	0.00392	0.00827	CcSEcCtD
Hydroxocobalamin—Lung disorder—Methotrexate—bone cancer	0.0038	0.00801	CcSEcCtD
Hydroxocobalamin—Redness—Epirubicin—bone cancer	0.00373	0.00786	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—bone cancer	0.0037	0.00781	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Cisplatin—bone cancer	0.00357	0.00753	CcSEcCtD
Hydroxocobalamin—Thrombosis—Epirubicin—bone cancer	0.00356	0.0075	CcSEcCtD
Hydroxocobalamin—Lung disorder—Epirubicin—bone cancer	0.00356	0.0075	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Methotrexate—bone cancer	0.00351	0.0074	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—bone cancer	0.00345	0.00727	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—bone cancer	0.00329	0.00694	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—bone cancer	0.00329	0.00694	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Epirubicin—bone cancer	0.00329	0.00693	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Cisplatin—bone cancer	0.00324	0.00683	CcSEcCtD
Hydroxocobalamin—Feeling hot—Epirubicin—bone cancer	0.00321	0.00676	CcSEcCtD
Hydroxocobalamin—Extravasation—Methotrexate—bone cancer	0.00308	0.0065	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—bone cancer	0.00304	0.00641	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—bone cancer	0.00297	0.00626	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Cisplatin—bone cancer	0.00295	0.00621	CcSEcCtD
Hydroxocobalamin—Extravasation—Epirubicin—bone cancer	0.00288	0.00608	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Epirubicin—bone cancer	0.00279	0.00587	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—bone cancer	0.00267	0.00563	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00258	0.00544	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—bone cancer	0.0025	0.00527	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Cisplatin—bone cancer	0.00243	0.00512	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Cisplatin—bone cancer	0.00241	0.00509	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—bone cancer	0.00239	0.00505	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—bone cancer	0.00231	0.00488	CcSEcCtD
Hydroxocobalamin—Eye disorder—Cisplatin—bone cancer	0.0023	0.00485	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Cisplatin—bone cancer	0.00228	0.00482	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—bone cancer	0.00224	0.00472	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Cisplatin—bone cancer	0.00222	0.00469	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Cisplatin—bone cancer	0.00222	0.00468	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Cisplatin—bone cancer	0.0022	0.00464	CcSEcCtD
Hydroxocobalamin—Erythema—Cisplatin—bone cancer	0.00214	0.00452	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—bone cancer	0.00212	0.00447	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—bone cancer	0.00207	0.00437	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—bone cancer	0.00203	0.00429	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—bone cancer	0.00201	0.00425	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Cisplatin—bone cancer	0.00199	0.00419	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—bone cancer	0.00196	0.00414	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—bone cancer	0.00195	0.00412	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—bone cancer	0.00194	0.00408	CcSEcCtD
Hydroxocobalamin—Malaise—Cisplatin—bone cancer	0.00193	0.00407	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—bone cancer	0.00191	0.00403	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—bone cancer	0.00188	0.00397	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—bone cancer	0.00186	0.00393	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—bone cancer	0.00183	0.00387	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00181	0.00382	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—bone cancer	0.00181	0.00381	CcSEcCtD
Hydroxocobalamin—Discomfort—Cisplatin—bone cancer	0.0018	0.0038	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—bone cancer	0.00179	0.00378	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—bone cancer	0.00177	0.00373	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cisplatin—bone cancer	0.00175	0.00369	CcSEcCtD
Hydroxocobalamin—Oedema—Cisplatin—bone cancer	0.00175	0.00369	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—bone cancer	0.00174	0.00366	CcSEcCtD
Hydroxocobalamin—Infection—Cisplatin—bone cancer	0.00174	0.00366	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cisplatin—bone cancer	0.00171	0.00362	CcSEcCtD
Hydroxocobalamin—Tachycardia—Cisplatin—bone cancer	0.00171	0.0036	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cisplatin—bone cancer	0.0017	0.00358	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—bone cancer	0.0017	0.00358	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—bone cancer	0.00166	0.00351	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—bone cancer	0.00162	0.00341	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—bone cancer	0.00161	0.00339	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—bone cancer	0.00158	0.00333	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Cisplatin—bone cancer	0.00156	0.00329	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—bone cancer	0.00154	0.00324	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cisplatin—bone cancer	0.00151	0.00318	CcSEcCtD
Hydroxocobalamin—Pain—Cisplatin—bone cancer	0.0015	0.00315	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—bone cancer	0.00146	0.00308	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cisplatin—bone cancer	0.00144	0.00304	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cisplatin—bone cancer	0.00138	0.00291	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—bone cancer	0.00133	0.00281	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—bone cancer	0.00132	0.00279	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cisplatin—bone cancer	0.00129	0.00272	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—bone cancer	0.00126	0.00266	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—bone cancer	0.00125	0.00264	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—bone cancer	0.00125	0.00263	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—bone cancer	0.00125	0.00262	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—bone cancer	0.00124	0.00261	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—bone cancer	0.00123	0.00258	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—bone cancer	0.00122	0.00257	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—bone cancer	0.00122	0.00257	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—bone cancer	0.00121	0.00255	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cisplatin—bone cancer	0.0012	0.00252	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—bone cancer	0.00118	0.00249	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—bone cancer	0.00118	0.00249	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—bone cancer	0.00118	0.00248	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—bone cancer	0.00117	0.00247	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—bone cancer	0.00115	0.00243	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—bone cancer	0.00115	0.00243	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—bone cancer	0.00115	0.00242	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—bone cancer	0.00115	0.00242	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—bone cancer	0.00114	0.00241	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—bone cancer	0.00114	0.0024	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—bone cancer	0.00113	0.00239	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—bone cancer	0.00113	0.00238	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—bone cancer	0.00111	0.00233	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—bone cancer	0.0011	0.00232	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—bone cancer	0.0011	0.00232	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—bone cancer	0.0011	0.00232	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—bone cancer	0.00109	0.0023	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—bone cancer	0.00109	0.0023	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—bone cancer	0.00109	0.00229	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—bone cancer	0.00106	0.00224	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—bone cancer	0.00106	0.00224	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—bone cancer	0.00106	0.00223	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—bone cancer	0.00105	0.00222	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—bone cancer	0.00105	0.00221	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—bone cancer	0.00104	0.0022	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—bone cancer	0.00104	0.00219	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—bone cancer	0.00102	0.00216	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—bone cancer	0.00102	0.00215	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—bone cancer	0.00102	0.00215	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—bone cancer	0.00101	0.00213	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—bone cancer	0.001	0.00211	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000994	0.0021	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—bone cancer	0.000992	0.00209	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—bone cancer	0.000989	0.00208	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—bone cancer	0.000959	0.00202	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—bone cancer	0.000953	0.00201	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—bone cancer	0.000945	0.00199	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—bone cancer	0.000941	0.00198	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—bone cancer	0.000937	0.00197	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—bone cancer	0.000935	0.00197	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—bone cancer	0.000932	0.00196	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00093	0.00196	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—bone cancer	0.000925	0.00195	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—bone cancer	0.000918	0.00194	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—bone cancer	0.000898	0.00189	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—bone cancer	0.000898	0.00189	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000893	0.0017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KIT—bone cancer	0.000892	0.0017	CbGpPWpGaD
Hydroxocobalamin—Infection—Epirubicin—bone cancer	0.000892	0.00188	CcSEcCtD
Hydroxocobalamin—MMAB—Metabolism—ENO2—bone cancer	0.000883	0.00168	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ENO2—bone cancer	0.000883	0.00168	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Epirubicin—bone cancer	0.000881	0.00186	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—bone cancer	0.000876	0.00185	CcSEcCtD
Hydroxocobalamin—AMN—Disease—ENO2—bone cancer	0.000874	0.00166	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ENO2—bone cancer	0.000874	0.00166	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Epirubicin—bone cancer	0.000872	0.00184	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—bone cancer	0.000867	0.00183	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000861	0.00181	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR—BRAF—bone cancer	0.000859	0.00163	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Doxorubicin—bone cancer	0.000856	0.00181	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—bone cancer	0.000855	0.0018	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KIT—bone cancer	0.000851	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KIT—bone cancer	0.000851	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KIT—bone cancer	0.000851	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000851	0.00162	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Methotrexate—bone cancer	0.000845	0.00178	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—KIT—bone cancer	0.000844	0.00161	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GNA11—bone cancer	0.000837	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TP53—bone cancer	0.000837	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KIT—bone cancer	0.000836	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—BRAF—bone cancer	0.000834	0.00159	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ENO2—bone cancer	0.000834	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KIT—bone cancer	0.000833	0.00158	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—bone cancer	0.000831	0.00175	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—bone cancer	0.000831	0.00175	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000828	0.00175	CcSEcCtD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—bone cancer	0.000827	0.00157	CbGpPWpGaD
Hydroxocobalamin—Infection—Doxorubicin—bone cancer	0.000825	0.00174	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—ENO2—bone cancer	0.000821	0.00156	CbGpPWpGaD
Hydroxocobalamin—Pain—Methotrexate—bone cancer	0.00082	0.00173	CcSEcCtD
Hydroxocobalamin—MMAB—Metabolism—DHFR—bone cancer	0.00082	0.00156	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—DHFR—bone cancer	0.00082	0.00156	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—bone cancer	0.000818	0.00156	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—EGFR—bone cancer	0.000816	0.00155	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—bone cancer	0.000815	0.00172	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—bone cancer	0.000811	0.00171	CcSEcCtD
Hydroxocobalamin—AMN—Disease—DHFR—bone cancer	0.000811	0.00154	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—DHFR—bone cancer	0.000811	0.00154	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Doxorubicin—bone cancer	0.000807	0.0017	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MDM2—bone cancer	0.000804	0.00153	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Epirubicin—bone cancer	0.000801	0.00169	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—BRAF—bone cancer	0.0008	0.00152	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—bone cancer	0.000799	0.00152	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Methotrexate—bone cancer	0.000791	0.00167	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—bone cancer	0.00079	0.00167	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—KIT—bone cancer	0.000788	0.0015	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TGFBR2—bone cancer	0.000775	0.00147	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000775	0.00163	CcSEcCtD
Hydroxocobalamin—MUT—Disease—DHFR—bone cancer	0.000774	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—MDM2—bone cancer	0.00077	0.00146	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ENO2—bone cancer	0.000769	0.00146	CbGpPWpGaD
Hydroxocobalamin—Pain—Epirubicin—bone cancer	0.000768	0.00162	CcSEcCtD
Hydroxocobalamin—TCN1—Metabolism—GNA11—bone cancer	0.000766	0.00146	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GNA11—bone cancer	0.000766	0.00146	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Methotrexate—bone cancer	0.000762	0.00161	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—DHFR—bone cancer	0.000762	0.00145	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000761	0.00145	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—CYP3A4—bone cancer	0.000759	0.00144	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Methotrexate—bone cancer	0.000758	0.0016	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—MDM2—bone cancer	0.000757	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000754	0.00143	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Doxorubicin—bone cancer	0.000741	0.00156	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—bone cancer	0.00074	0.00156	CcSEcCtD
Hydroxocobalamin—CASP9—PI-3K cascade—EGFR—bone cancer	0.000735	0.0014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—bone cancer	0.000734	0.0014	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ENO2—bone cancer	0.000732	0.00139	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ENO2—bone cancer	0.000732	0.00139	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Doxorubicin—bone cancer	0.000731	0.00154	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—MDM2—bone cancer	0.000723	0.00138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—MDM2—bone cancer	0.00072	0.00137	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—EGFR—bone cancer	0.000718	0.00137	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000717	0.00151	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB2—MDM2—bone cancer	0.000716	0.00136	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—DHFR—bone cancer	0.000714	0.00136	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Epirubicin—bone cancer	0.000713	0.0015	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 signaling—MDM2—bone cancer	0.000713	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—EGFR—bone cancer	0.000712	0.00135	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GNA11—bone cancer	0.000712	0.00135	CbGpPWpGaD
Hydroxocobalamin—Pain—Doxorubicin—bone cancer	0.00071	0.0015	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—bone cancer	0.00071	0.0015	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—TGFBR2—bone cancer	0.000709	0.00135	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFBR2—bone cancer	0.000709	0.00135	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000709	0.00135	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Methotrexate—bone cancer	0.000707	0.00149	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000703	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—bone cancer	0.000698	0.00133	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ENO2—bone cancer	0.000698	0.00133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	0.000696	0.00132	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—CYP3A4—bone cancer	0.000694	0.00132	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CYP3A4—bone cancer	0.000694	0.00132	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—bone cancer	0.000685	0.00144	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MMP9—bone cancer	0.00068	0.00129	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—DHFR—bone cancer	0.000679	0.00129	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—DHFR—bone cancer	0.000679	0.00129	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Methotrexate—bone cancer	0.000679	0.00143	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—MDM2—bone cancer	0.000671	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—MDM2—bone cancer	0.000671	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.000671	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—MDM2—bone cancer	0.000665	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000662	0.00126	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Epirubicin—bone cancer	0.000662	0.00139	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—bone cancer	0.00066	0.00139	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—TGFBR2—bone cancer	0.000659	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—MDM2—bone cancer	0.000659	0.00125	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Doxorubicin—bone cancer	0.000657	0.00138	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—bone cancer	0.000656	0.00138	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—MDM2—bone cancer	0.000656	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—bone cancer	0.000655	0.00125	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GSTP1—bone cancer	0.000649	0.00124	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—DHFR—bone cancer	0.000648	0.00123	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CYP3A4—bone cancer	0.000646	0.00123	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ENO2—bone cancer	0.000644	0.00123	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Epirubicin—bone cancer	0.000635	0.00134	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—GNA11—bone cancer	0.000635	0.00121	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GNA11—bone cancer	0.000635	0.00121	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Methotrexate—bone cancer	0.000634	0.00134	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—ENO2—bone cancer	0.000632	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000631	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—MDM2—bone cancer	0.000621	0.00118	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Epirubicin—bone cancer	0.000614	0.0013	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—bone cancer	0.000612	0.00129	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000608	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—JUN—bone cancer	0.000608	0.00116	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GNA11—bone cancer	0.000605	0.00115	CbGpPWpGaD
Hydroxocobalamin—Rash—Methotrexate—bone cancer	0.000605	0.00128	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—bone cancer	0.000604	0.00127	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—bone cancer	0.000601	0.00127	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—DHFR—bone cancer	0.000598	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000594	0.00113	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GSTP1—bone cancer	0.000594	0.00113	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GSTP1—bone cancer	0.000594	0.00113	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Epirubicin—bone cancer	0.000594	0.00125	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—bone cancer	0.000588	0.00124	CcSEcCtD
Hydroxocobalamin—MMAA—Disease—TGFBR2—bone cancer	0.000588	0.00112	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFBR2—bone cancer	0.000588	0.00112	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—DHFR—bone cancer	0.000586	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	0.000583	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ATF1—bone cancer	0.000581	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KIT—bone cancer	0.00058	0.0011	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CYP3A4—bone cancer	0.000575	0.00109	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CYP3A4—bone cancer	0.000575	0.00109	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000572	0.00109	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000572	0.00109	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methotrexate—bone cancer	0.00057	0.0012	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—bone cancer	0.000568	0.0012	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—bone cancer	0.000566	0.00119	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—bone cancer	0.000566	0.00119	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—bone cancer	0.000563	0.00119	CcSEcCtD
Hydroxocobalamin—MUT—Disease—TGFBR2—bone cancer	0.000561	0.00107	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GNA11—bone cancer	0.000559	0.00106	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GSTP1—bone cancer	0.000552	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—EGFR—bone cancer	0.00055	0.00105	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Doxorubicin—bone cancer	0.000549	0.00116	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—CYP3A4—bone cancer	0.000549	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000548	0.00104	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000546	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—BRAF—bone cancer	0.000545	0.00104	CbGpPWpGaD
Hydroxocobalamin—Nausea—Epirubicin—bone cancer	0.000533	0.00112	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—ENO2—bone cancer	0.000529	0.00101	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KIT—bone cancer	0.000529	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—EGFR—bone cancer	0.000526	0.001	CbGpPWpGaD
Hydroxocobalamin—Rash—Doxorubicin—bone cancer	0.000524	0.0011	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—bone cancer	0.000523	0.0011	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—bone cancer	0.00052	0.0011	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.00052	0.00099	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—EGFR—bone cancer	0.000518	0.000985	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFBR2—bone cancer	0.000517	0.000984	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ENO2—bone cancer	0.000515	0.00098	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CYP3A4—bone cancer	0.000507	0.000964	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000504	0.000959	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—BRAF—bone cancer	0.000497	0.000946	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—EGFR—bone cancer	0.000494	0.00094	CbGpPWpGaD
Hydroxocobalamin—Nausea—Doxorubicin—bone cancer	0.000493	0.00104	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—GSTP1—bone cancer	0.000492	0.000936	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GSTP1—bone cancer	0.000492	0.000936	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—EGFR—bone cancer	0.000492	0.000936	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—DHFR—bone cancer	0.000491	0.000934	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—EGFR—bone cancer	0.000489	0.000931	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—EGFR—bone cancer	0.000487	0.000927	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KIT—bone cancer	0.000484	0.00092	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KIT—bone cancer	0.000484	0.00092	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.00048	0.000913	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—DHFR—bone cancer	0.000478	0.000909	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—EGFR—bone cancer	0.000478	0.000909	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GSTP1—bone cancer	0.000469	0.000893	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GNA11—bone cancer	0.000459	0.000873	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—EGFR—bone cancer	0.000458	0.000872	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000458	0.000872	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—EGFR—bone cancer	0.000458	0.000872	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—MDM2—bone cancer	0.000457	0.000869	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—BRAF—bone cancer	0.000455	0.000865	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—BRAF—bone cancer	0.000455	0.000865	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—EGFR—bone cancer	0.000454	0.000864	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—EGFR—bone cancer	0.00045	0.000856	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KIT—bone cancer	0.00045	0.000856	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—EGFR—bone cancer	0.000448	0.000853	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000437	0.000831	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GSTP1—bone cancer	0.000433	0.000824	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO2—bone cancer	0.000431	0.000821	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000431	0.00082	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—bone cancer	0.000428	0.000814	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFBR2—bone cancer	0.000425	0.000808	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—EGFR—bone cancer	0.000424	0.000807	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—BRAF—bone cancer	0.000423	0.000804	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GRM4—bone cancer	0.000421	0.000802	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RGS1—bone cancer	0.000421	0.000802	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MDM2—bone cancer	0.000417	0.000793	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP3A4—bone cancer	0.000416	0.000791	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000406	0.000772	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTGS2—bone cancer	0.000402	0.000764	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—bone cancer	0.000401	0.000763	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KIT—bone cancer	0.000401	0.000763	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KIT—bone cancer	0.000401	0.000763	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—DHFR—bone cancer	0.0004	0.000761	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ENO2—bone cancer	0.000388	0.000738	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KIT—bone cancer	0.000383	0.000728	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MDM2—bone cancer	0.000381	0.000725	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MDM2—bone cancer	0.000381	0.000725	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—BRAF—bone cancer	0.000377	0.000717	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—BRAF—bone cancer	0.000377	0.000717	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GNA11—bone cancer	0.000374	0.000712	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—bone cancer	0.000367	0.000699	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—bone cancer	0.000367	0.000699	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GRM1—bone cancer	0.000365	0.000695	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000362	0.000689	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—DHFR—bone cancer	0.00036	0.000684	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—BRAF—bone cancer	0.00036	0.000684	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GSTP1—bone cancer	0.000356	0.000677	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MDM2—bone cancer	0.000354	0.000674	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KIT—bone cancer	0.000353	0.000672	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFBR2—bone cancer	0.000346	0.000659	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—bone cancer	0.000342	0.00065	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP3A4—bone cancer	0.000339	0.000645	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ATF1—bone cancer	0.000339	0.000644	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—bone cancer	0.000336	0.00064	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—BRAF—bone cancer	0.000332	0.000631	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KIT—bone cancer	0.000331	0.000629	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL3—bone cancer	0.00033	0.000628	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIT—bone cancer	0.000318	0.000604	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MDM2—bone cancer	0.000316	0.000601	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MDM2—bone cancer	0.000316	0.000601	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—bone cancer	0.000312	0.000594	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—bone cancer	0.000308	0.000585	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—bone cancer	0.000308	0.000585	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—bone cancer	0.000304	0.000579	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—bone cancer	0.000304	0.000579	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MDM2—bone cancer	0.000301	0.000573	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—bone cancer	0.00029	0.000552	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTP1—bone cancer	0.00029	0.000552	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KIT—bone cancer	0.00029	0.000551	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—bone cancer	0.000286	0.000544	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—bone cancer	0.000285	0.000542	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MDM2—bone cancer	0.000278	0.000529	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—BRAF—bone cancer	0.000272	0.000518	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—bone cancer	0.000268	0.00051	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFBR2—bone cancer	0.000261	0.000496	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MDM2—bone cancer	0.000261	0.000496	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—bone cancer	0.00026	0.000495	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—bone cancer	0.00026	0.000495	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMO—bone cancer	0.000257	0.00049	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—bone cancer	0.000255	0.000485	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—bone cancer	0.000255	0.000485	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MDM2—bone cancer	0.00025	0.000476	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—bone cancer	0.000243	0.000463	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—bone cancer	0.000242	0.000461	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—bone cancer	0.000236	0.00045	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNA11—bone cancer	0.000235	0.000448	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MDM2—bone cancer	0.000228	0.000434	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—bone cancer	0.000226	0.000431	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—bone cancer	0.000224	0.000427	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—bone cancer	0.000222	0.000423	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—bone cancer	0.00022	0.000419	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATF1—bone cancer	0.000219	0.000416	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—bone cancer	0.000216	0.00041	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—bone cancer	0.000216	0.00041	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL3—bone cancer	0.000213	0.000406	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—bone cancer	0.000206	0.000392	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—bone cancer	0.000193	0.000367	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—bone cancer	0.00019	0.000361	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—bone cancer	0.000186	0.000354	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—bone cancer	0.000184	0.000351	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—bone cancer	0.000183	0.000347	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—bone cancer	0.000179	0.000341	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—bone cancer	0.000178	0.000339	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—bone cancer	0.000178	0.000338	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—bone cancer	0.000172	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—bone cancer	0.000171	0.000325	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—bone cancer	0.000167	0.000318	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—bone cancer	0.000156	0.000297	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—bone cancer	0.000152	0.000289	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—bone cancer	0.00015	0.000286	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—bone cancer	0.00014	0.000267	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—bone cancer	0.000135	0.000257	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—bone cancer	0.000132	0.000251	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—bone cancer	0.000127	0.000242	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—bone cancer	0.000125	0.000237	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—bone cancer	0.000117	0.000223	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—bone cancer	0.000104	0.000197	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—bone cancer	9.81e-05	0.000187	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—bone cancer	9.58e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—bone cancer	8.53e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—bone cancer	8.3e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—bone cancer	6.71e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—bone cancer	5.63e-05	0.000107	CbGpPWpGaD
